Trial · NCT03498716
Results by group136
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 136
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Invasive Disease-Free Survival (iDFS) | Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Invasive Disease-Free Survival (iDFS) | Atezolizumab and Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Invasive Disease-Free Survival (iDFS) in the Subpopulation With Programmed Death-ligand 1 (PD-L1) Selected Tumor Status (IC1/2/3) | Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Invasive Disease-Free Survival (iDFS) in the Subpopulation With Programmed Death-ligand 1 (PD-L1) Selected Tumor Status (IC1/2/3) | Atezolizumab and Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Invasive Disease-Free Survival (iDFS) in the Node Positive Subpopulation | Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Invasive Disease-Free Survival (iDFS) in the Node Positive Subpopulation | Atezolizumab and Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Overall Survival (OS) | Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Overall Survival (OS) | Atezolizumab and Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Invasive Disease-Free Survival (iDFS) Including Second Primary Non-Breast Invasive Cancer | Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Invasive Disease-Free Survival (iDFS) Including Second Primary Non-Breast Invasive Cancer | Atezolizumab and Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Recurrence-Free Interval (RFI) | Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Recurrence-Free Interval (RFI) | Atezolizumab and Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Distant Recurrence-Free Interval (DRFI) | Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Distant Recurrence-Free Interval (DRFI) | Atezolizumab and Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Disease-Free Survival (DFS) | Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Disease-Free Survival (DFS) | Atezolizumab and Chemotherapy | NA | 95% Confidence Interval NA to NA | months | |
| Change From Baseline (CFB) in European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) Patient-reported Function (Role Functioning [Q6, Q7]) | Chemotherapy | Baseline | 87.26 | Standard Deviation 18.92 | score on scale |
| Change From Baseline (CFB) in European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) Patient-reported Function (Role Functioning [Q6, Q7]) | Atezolizumab and Chemotherapy | Baseline | 86.43 | Standard Deviation 19.66 | score on scale |
| Change From Baseline (CFB) in European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) Patient-reported Function (Role Functioning [Q6, Q7]) | Chemotherapy | CFB: Cycle 4 Day 1 | -10.88 | Standard Deviation 25.00 | score on scale |
| Change From Baseline (CFB) in European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) Patient-reported Function (Role Functioning [Q6, Q7]) | Atezolizumab and Chemotherapy | CFB: Cycle 4 Day 1 | -10.26 | Standard Deviation 24.87 | score on scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03498716/results